IL2 and cancer: PD-L1 expression on tumor cells and tumor-associated immune cells was also positively correlated with the progression of human malignant tumors.49 PD-1 is expressed by activated T cells50 and its engagement with PD-L1 inhibits TCR-mediated activation of IL-2 production and T-cell proliferation.